September 5, 2023

Susan Magsamen, MAS, Co-author of Your Brain on Art, How the Arts Transform Us (part 2)

Susan Magsamen, MAS, Co-author of Your Brain on Art, How the Arts Transform Us (part 2)

About This Episode

What do technology, AI and the Arts have in common? In part 2 of an interview with Susan Magsamen, founder and director of the International Arts and Mind Lab Center for Applied Neuroaesthetics at Johns Hopkins University School of Medicine, Ms. Magsamen talks with BrainStorm host Meryl Comer about how technology and AI are best used to advance the evolving science of neuroaesthetics. Neuroaesthetics is an expanding field of research aimed at the intersection of psychological aesthetics, biological mechanisms, and human evolution. Ms. Magsamen is also co-author of the New York Times Bestseller, Your Brain on Art, How the Arts Transform Us

Produced by Susan Quirk and Amber Roniger.

BrainStorm Feed

100

2025 Year in Review and Predictions for 2026 with George Vradenburg

George Vradenburg, Chairman and Founder of UsAgainstAlzheimer's, sits down with host Meryl Comer for a comprehensive look at the state of Alzheimer's research, advocacy, and care in 2025.
LISTEN NOW
99

The Future of Alzheimer's Trials: AI, Biomarkers, and Remote Research – John Dwyer, CEO of The Global Alzheimer’s Platform (part 2)

In part 2 John Dwyer, CEO of the Global Alzheimer's Platform (GAP), and BrainStorm host Meryl Comer discuss transforming Alzheimer's research and clinical trials.
LISTEN NOW
98

The Future of Alzheimer's Trials: Bringing Cutting-Edge Research to Every Community - John Dwyer, CEO of The Global Alzheimer's Platform

John Dwyer, CEO of the Global Alzheimer's Platform (GAP), highlights GAP's innovations in improving the participant experience through streamlining visits, personalized feedback, and bringing mobile trials directly to small communities.
LISTEN NOW